Teva Pharmaceutical Industries Ltd. v. Torrent Pharmaceuticals Ltd.
1:07-cv-00024
Overview
Parties
Defendant
Torrent Pharmaceuticals Ltd. Operating Company
Represented By
0 Attorneys ListedTeva Pharmaceutical Industries Ltd. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Teva Pharmaceuticals U.S.A., Inc. Operating Company
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,600,073 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,500,987 B1 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6600073
Methods for preparation of sertraline hydrochloride polymorphs
|
Filed: 2000-06-05
Issued: 2003-07-29
|
Expired (Term Ended)
Expires: 2020-06-05
|
|
|
US6500987
Sertraline hydrochloride polymorphs
|
Filed: 1999-11-24
Issued: 2002-12-31
|
Expired (Term Ended)
Expires: 2019-11-24
|
|
|
US6495721
Sertraline hydrochloride Form II and methods for the preparation thereof
|
Filed: 2000-05-22
Issued: 2002-12-17
|
Expired (Term Ended)
Expires: 2020-05-22
|
|
|
US6897340
Processes for preparation of polymorphic form II of sertraline hydrochloride
|
Filed: 2003-04-29
Issued: 2005-05-24
|
Expired (Term Ended)
Expires: 2023-04-29
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).